Viewing Study NCT04896112

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2026-03-20 @ 2:09 PM
Study NCT ID: NCT04896112
Status: WITHDRAWN
Last Update Posted: 2023-06-18
First Post: 2021-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia
Sponsor: Lynk Pharmaceuticals Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Primary Myelofibrosis View
None Post-polycythemia Vera Myelofibrosis View
None Post-essential Thrombocythemia Myelofibrosis View
None Polycythemia Vera View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant Myeloid Hematologic Neoplasms View
None Primary Myelofibrosis View
None Post-polycythemia Vera Myelofibrosis View
None Post-essential Thrombocythemia Myelofibrosis View
None Myeloid malignancies View
None Myelofibrosis View
None Polycythemia Vera View
None Acute Myeloid Leukemia View